Roivant shares rise as mosliciguat data boosts 6-minute walk
Roivant Sciences shares rose after data showed once-daily inhaled mosliciguat reduced pulmonary vascular pressure and resistance and increased 6-minute walk distance by 52.7 m at 24 weeks, with no major safety issues reported; TD Cowen and HC Wainwright raised price targets.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.